Incannex Healthcare (IXHL) Interest & Investment Income (2022 - 2025)

Incannex Healthcare (IXHL) has reported Interest & Investment Income for 4 consecutive years, with $2000.0 the latest figure, recorded in Q2 2025.

• Quarterly Interest & Investment Income fell 95.0% year-over-year to $2000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $62000.0 (down 69.9% YoY) and the FY2025 annual result came in at $62000.0, down 69.9% from the prior year.
• Interest & Investment Income eased to $2000.0 in Q2 2025 per IXHL's latest filing, from $4000.0 in the prior quarter.
• Over the last five years, Interest & Investment Income for IXHL reached as high as $163000.0 in Q1 2023 and fell as low as $2000.0 in Q2 2025.
• A 4-year average of $52181.8 and a median of $40000.0 in 2024 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2024 — Interest & Investment Income surged 40.0% — and 2025, when it sank 95.0%.
• Year by year, Interest & Investment Income stood at $55000.0 in 2022, then sank by 63.64% to $20000.0 in 2023, then jumped by 40.0% to $28000.0 in 2024, then slumped by 92.86% to $2000.0 in 2025.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $2000.0, $4000.0, and $28000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.